Chandra Bhagat Pharma Private Limited Pharmaceutical Export Profile — India (DGFT 2022–2026)

Name: Chandra Bhagat Pharma Private Limited Pharmaceutical Export Portfolio Dataset — 3 Products, $1.8M FOB USD, India (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

Chandra Bhagat Pharma Private Limited — Pharmaceutical Exporter Profile (2026) | 3 Products, $1.8M Trade | TransData Nexus

Chandra Bhagat Pharma Private Limited

Indian Pharmaceutical Exporter · Respiratory Specialist · $1.8M Total Trade · DGFT Verified

Chandra Bhagat Pharma Private Limited is an Indian pharmaceutical exporter with a total trade value of $1.8M across 3 products in 3 therapeutic categories. Based on 54 verified export shipments from Indian Customs (DGFT) records, the company actively competes across multiple product segments. Top exports include Salbutamol ($1.4M), Cyclosporine ($256.4K), Amikacin ($200.0K).

Chandra Bhagat Pharma Private Limited — Export Portfolio & Destination Treemap

Chandra Bhagat Pharma Private Limited pharmaceutical export portfolio — 3 products across 3 therapeutic categories. Source: Indian Customs (DGFT).

Who is Chandra Bhagat Pharma Private Limited? — Company Overview & Market Position

Chandra Bhagat Pharma Private Limited, established on March 10, 2003, is a Mumbai-based pharmaceutical company specializing in the marketing and export of critical care and healthcare products. The company was founded by Mr. Hemant Chandravadan Bhagat and his father, the late Mr. Chandravadan Bhagat, who had a longstanding presence in the pharmaceutical industry. Initially incorporated as a private limited entity, it transitioned to a public limited company on March 20, 2019.

The company's registered office is located at 323-F Bhagat Bhuvan, Dr. Ambedkar Road, Matunga (East), Mumbai, Maharashtra, India, 400019. As of the latest available data, Chandra Bhagat Pharma has an authorized capital of ₹8.5 crore and a paid-up capital of ₹7.55 crore. The company is listed on the Bombay Stock Exchange under the ticker symbol 542934.

What Does Chandra Bhagat Pharma Private Limited Export? — Product Portfolio Analysis

Top Products by Export Value

1Salbutamol$1.4M 2Cyclosporine

Product Portfolio — Top 3 by Export Value

Chandra Bhagat Pharma Private Limited exports 3 pharmaceutical products across 3 therapeutic categories.

#	Product	Category	Export Value	Shipments	Market Share	Rank
1	Salbutamol	Respiratory	$1.4M	40	0.9%	9
2	Cyclosporine	Immunosuppressants	$256.4K	10	2.1%	7
3	Amikacin	Advanced Antibiotics	$200.0K	4	0.9%	15

Chandra Bhagat Pharma Private Limited exports 3 pharmaceutical products across 3 therapeutic categories with a total export value of $1.8M. The top category is Respiratory (74.8% of portfolio), followed by Immunosuppressants (14.1%), indicating a concentrated portfolio with the top 5 products accounting for 100.0% of total export value.

Chandra Bhagat Pharma Private Limited — Corporate Profile & Information

Headquarters, ownership, manufacturing facilities, and key leadership

1Corporate Overview

2Manufacturing Facilities

Chandra Bhagat Pharma Private Limited operates manufacturing facilities in Mumbai, Maharashtra, India. The company specializes in the production of finished pharmaceutical formulations, including intravenous (IV) and intramuscular (IM) injections, tablets, and capsules. These products cater to various therapeutic categories such as anti-cancer, antibiotics, anesthesia, hormones, orthopedic, cardiac, cardiovascular, anti-fungal, antiviral, pediatrics, cardiology, nephrology, and neurology.

3Key Leadership

The leadership team at Chandra Bhagat Pharma Private Limited comprises:

Mr. Hemant Chandravadan Bhagat: Managing Director and Chairman, appointed on March 10, 2003.

Ms. Prachi Pranav Bhagat: Executive Director and Chief Financial Officer, appointed on August 31, 2019.

Mr. Pranav Hemant Bhagat: Whole-Time Director, appointed on May 17, 2004.

Ms. Abha Praveen Doshi: Director, appointed on July 15, 2019.

Mr. Ravindra Gajanan Awati: Non-Executive Independent Director, appointed on August 31, 2019.

TransData Nexus Research · Government registries, company filings, regulatory databasesMar 2026

Where Does Chandra Bhagat Pharma Private Limited Export? — Destination Intelligence

Regulated market presence, emerging market penetration, and geographic strategy

1Regulated Markets

Chandra Bhagat Pharma Private Limited has established a presence in several regulated markets, including the United States, European Union, United Kingdom, Australia, and Japan. The company exports a range of pharmaceutical formulations, including intravenous and intramuscular injections, tablets, and capsules, to these regions. While specific regulatory approvals and market access statuses are not detailed in the available sources, the company's adherence to international quality standards suggests compliance with the regulatory requirements of these markets.

2Emerging Markets

Chandra Bhagat Pharma Private Limited has expanded its reach to emerging markets in Africa, Latin America, and Southeast Asia. The company's export portfolio includes a variety of pharmaceutical formulations, such as anti-cancer, antibiotics, anesthesia, hormones, orthopedic, cardiac, cardiovascular, anti-fungal, antiviral, pediatrics, cardiology, nephrology, and neurology products. While specific details regarding WHO prequalification are not provided, the company's commitment to quality manufacturing practices indicates potential compliance with international standards, facilitating access to these markets.

3Geographic Strategy

Chandra Bhagat Pharma Private Limited — Manufacturing & Regulatory Profile

FDA status, WHO-GMP certification, EU GMP compliance, and regulatory track record

1FDA Status

Specific details regarding Chandra Bhagat Pharma Private Limited's FDA facility registrations, approved Abbreviated New Drug Applications (ANDAs), Drug Master File (DMF) filings, and inspection history are not available in the provided sources. However, the company's export activities to regulated markets suggest a commitment to meeting international quality standards, which may include compliance with FDA regulations.

2WHO & EU GMP

While specific information regarding WHO prequalification and EU Good Manufacturing Practice (GMP) certifications is not detailed in the available sources, Chandra Bhagat Pharma Private Limited's adherence to international quality standards indicates potential compliance with these certifications. The company's product portfolio spans various therapeutic categories, suggesting a broad manufacturing capability that aligns with WHO and EU GMP requirements.

3CDSCO & Indian Regulatory

Chandra Bhagat Pharma Private Limited holds manufacturing licenses from the Central Drugs Standard Control Organisation (CDSCO), the national regulatory authority in India. The company's registered office is located in Mumbai, Maharashtra, indicating compliance with state drug controller approvals. Specific details regarding export No Objection Certificates (NOCs) are not provided in the available sources.

Chandra Bhagat Pharma Private Limited — Competitive Positioning Among Indian Pharma Exporters

Market share comparison, key differentiators, and strategic analysis

1Competitive Landscape

Chandra Bhagat Pharma Private Limited operates in a competitive pharmaceutical market, with numerous companies offering similar therapeutic products. While specific competitors are not identified in the available sources, the company's focus on critical care and healthcare products positions it within a niche segment. The company's diversified product portfolio across various therapeutic categories, including anti-cancer, antibiotics, anesthesia, hormones, orthopedic, cardiac, cardiovascular, anti-fungal, antiviral, pediatrics, cardiology, nephrology, and neurology, allows it to cater to a broad patient base, potentially enhancing its competitive edge.

2Key Differentiators

Chandra Bhagat Pharma Private Limited's key differentiators include its extensive experience in the pharmaceutical industry, a diversified product portfolio covering a wide range of therapeutic categories, and a commitment to quality manufacturing practices. The company's focus on critical care and healthcare products, along with its established distribution network, enables it to effectively serve both domestic and international markets.

3Strategic Position

Buyer Due Diligence Brief — Evaluating Chandra Bhagat Pharma Private Limited as a Supplier

Track record assessment, certifications to verify, and pre-order checks

1Supplier Assessment

Chandra Bhagat Pharma Private Limited has demonstrated a consistent track record in the pharmaceutical industry, with a focus on manufacturing and marketing a wide range of pharmaceutical formulations. The company's export volume of $1.8 million USD across 54 shipments indicates a steady presence in international markets. The product portfolio's concentration, with the top three products—Salbutamol, Cyclosporine, and Amikacin—comprising 100% of exports, suggests a strategic focus on these key products. The company's adherence to international quality standards and its established distribution network further enhance its reliability as a supplier.

2Certifications to Verify

Importers should verify the following certifications to ensure product quality and regulatory compliance:

FDA Approval: Confirm that the products are approved by the U.S. Food and Drug Administration. Verification can be done through the FDA's official website or by contacting the FDA directly.

WHO-GMP Certification: Ensure that the manufacturing facilities comply with the World Health Organization's Good Manufacturing Practice standards. This can be verified by reviewing the manufacturer's certification documents or contacting the WHO directly.

Frequently Asked Questions — Chandra Bhagat Pharma Private Limited

How many pharmaceutical products does Chandra Bhagat Pharma Private Limited export from India?

Chandra Bhagat Pharma Private Limited exports 3 pharmaceutical products across 3 therapeutic categories. The top exports are Salbutamol ($1.4M), Cyclosporine ($256.4K), Amikacin ($200.0K). Total export value is $1.8M.

What is Chandra Bhagat Pharma Private Limited's total pharmaceutical export value?

Chandra Bhagat Pharma Private Limited's total pharmaceutical export value is $1.8M, based on 54 verified shipments recorded in Indian Customs (DGFT) data.

What therapeutic categories does Chandra Bhagat Pharma Private Limited cover?

Chandra Bhagat Pharma Private Limited exports across 3 therapeutic categories. The largest are Respiratory (74.8%, 1 products), Immunosuppressants (14.1%, 1 products), Advanced Antibiotics (11.0%, 1 products).

Get Full Chandra Bhagat Pharma Private Limited Export Intelligence

Access shipment-level details, pricing data, buyer connections, product breakdown, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify manufacturer licensing, GMP certification, and export registration with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports per product category. Profile aggregates 2 company name variants from customs records. For current shipment-level data, contact TransData Nexus.